News & Events RSS Feed

24 June 2013

Physiomics wins poster award at NC3Rs/Society of Biology Symposium 2013

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it won the second poster prize at the NC3Rs and Society of Biology Symposium held in London on 19 June 2013. The NC3Rs is the National Centre for the Replacement, Refinement & Reduction of Animals in Research. read more […]

20 June 2013

Physiomics awarded a Biomedical Catalyst GRANT from the UK Technology Strategy Board

Physiomics is pleased to announce that it has been awarded a GBP148,465 grant from the UK’s innovation agency, the Technology Strategy Board’s Biomedical Catalyst fund. The grant will provide additional support for the development of the Company’s flagship Virtual Tumour Clinical platform. Read more.

11 June 2013

Physiomics to present on the new R&D development at the Population Approach Group Europe meeting 2013 (“PAGE”)

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it is participating in the PAGE Meeting 2013, taking place at the Glasgow Royal Concert Hall, Glasgow,  on 11-14 June 2013. Dr Eric Fernandez, Dr Frances Brightman, and Dr Christophe Chassagnole will present on an updated version of drugCARD, on […]

10 June 2013

Presenting the Virtual Tumour Clinical service

The current Virtual Tumour platform is a mathematical model of a growing tumour which accurately predicts the outcome of xenograft experiments. The model can also be used as a start point to design first time in human clinical regimens. Physiomics is now developing Virtual Tumour Clinical, based on the same principles as the exiting platform […]

7 June 2013

NC3Rs/Society of Biology 3Rs Symposium

Dr Eric Fernandez will present a poster on reducing animal experiments with the Virtual Tumour at the NC3Rs/Society of Biology 3Rs Symposium on the 19 June 2013 in London. The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is an independent scientific organisation, which supports the UK science base by […]

6 June 2013

Physiomics signs contract for Virtual Tumour Clinical and data analysis services

Physiomics plc is pleased to announce that it has signed a contract with a biotechnology company to apply its new Virtual Tumour Clinical platform to their lead compound. The biotechnology company will pay an up-front technology access fee now and ongoing service fees as the project progresses. This represents the first commercial deal for Physiomics’ […]

23 May 2013

EPIC Biotech Conference

Dr Mark Chadwick will be attending this event in London on the 6th June 2013. Read more

Page 3 of 1412345...10...Last